EnginZyme

EnginZyme, a Swedish biotechnology firm founded in 2014, is commercializing a proprietary cell-free biomanufacturing platform aimed at transforming the chemical industry. The company was established by CEO Karim Engelmark Cassimjee and CSO Samuel Olofsson, both of whom have backgrounds in biochemistry and molecular biology from Stockholm University and KTH Royal Institute of Technology, respectively. Their academic research into enzyme immobilization laid the groundwork for EnginZyme's core technology. The company's mission is to facilitate the production of everyday products in a more sustainable manner, addressing the significant carbon footprint of the traditional chemical sector.

The core of EnginZyme's business is its technology platform, which immobilizes enzymes within a specially designed porous material, referred to as EziG, acting as a solid-state catalyst. This approach circumvents the complexities and limitations of traditional fermentation methods that rely on living cells. By using isolated enzymes, the platform allows for higher concentrations and yields, operating efficiently within the established infrastructure of the chemical industry. This 'best-of-both-worlds' solution merges the specificity and power of biological catalysts with the scalability and efficiency of chemical processing, enabling the production of chemicals with a significantly lower environmental impact.

EnginZyme operates on a business-to-business model, targeting major chemical producers and other industrial players seeking to decarbonize their manufacturing processes. Its revenue model is based on licensing its technology and forging joint development agreements to create sustainable production methods for a wide array of chemicals. A significant milestone was the inauguration of its pilot plant and innovation hub in Solna, Sweden, in late 2023, designed to demonstrate the technology's scalability and accelerate its adoption by industrial partners. The company has attracted substantial investment from prominent venture capital firms including Sofinnova Partners, Industrifonden, and SEB Greentech VC, underscoring investor confidence in its potential to disrupt the chemical manufacturing landscape.

Keywords: green chemistry, cell-free biomanufacturing, enzyme immobilization, sustainable chemicals, industrial biotechnology, decarbonization, biocatalysis, chemical manufacturing, EziG technology, cleantech